Thyroid Hormone May Regulate mRNA Abundance in Liver by Acting on MicroRNAs by Dong, Hongyan et al.
Thyroid Hormone May Regulate mRNA Abundance in
Liver by Acting on MicroRNAs
Hongyan Dong
1*, Martin Paquette
1, Andrew Williams
1, R. Thomas Zoeller
2, Mike Wade
1, Carole Yauk
1
1Environmental Health Sciences and Research Bureau, Health Canada, Ottawa, Ontario, Canada, 2Molecular and Cellular Biology Program, University of Massachusetts,
Amherst, Massachusetts, United States of America
Abstract
MicroRNAs (miRNAs) are extensively involved in diverse biological processes. However, very little is known about the role of
miRNAs in mediating the action of thyroid hormones (TH). Appropriate TH levels are known to be critically important for
development, differentiation and maintenance of metabolic balance in mammals. We induced transient hypothyroidism in
juvenile mice by short-term exposure to methimazole and perchlorate from post natal day (PND) 12 to 15. The expression of
miRNAs in the liver was analyzed using Taqman Low Density Arrays (containing up to 600 rodent miRNAs). We found the
expression of 40 miRNAs was significantly altered in the livers of hypothyroid mice compared to euthyroid controls. Among
the miRNAs, miRs-1, 206, 133a and 133b exhibited a massive increase in expression (50- to 500-fold). The regulation of TH
on the expression of miRs-1, 206, 133a and 133b was confirmed in various mouse models including: chronic hypothyroid,
short-term hyperthyroid and short-term hypothyroid followed by TH supplementation. TH regulation of these miRNAs was
also confirmed in mouse hepatocyte AML 12 cells. The expression of precursors of miRs-1, 206, 133a and 133b were
examined in AML 12 cells and shown to decrease after TH treatment, only pre-mir-206 and pre-mir-133b reached statistical
significance. To identify the targets of these miRNAs, DNA microarrays were used to examine hepatic mRNA levels in the
short-term hypothyroid mouse model relative to controls. We found transcripts from 92 known genes were significantly
altered in these hypothyroid mice. Web-based target predication software (TargetScan and Microcosm) identified 14 of
these transcripts as targets of miRs-1, 206, 133a and 133b. The vast majority of these mRNA targets were significantly down-
regulated in hypothyroid mice, corresponding with the up-regulation of miRs-1, 206, 133a and 133b in hypothyroid mouse
liver. To further investigate target genes, miR-206 was over-expressed in AML 12 cells. TH treatment of cells over-expressing
miR-206 resulted in decreased miR-206 expression, and a significant increase in two predicted target genes, Mup1 and
Gpd2. The results suggest that TH regulation of these genes may occur secondarily via miR-206. These studies provide new
insight into the role of miRNAs in mediating TH regulation of gene expression.
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Introduction
Thyroid hormones (TH) are critically important for develop-
ment, tissue differentiation, and maintenance of metabolic balance
in mammals through direct and indirect regulation of expression
in target genes [1]. Severe disruption of TH action during fetal
and early neonatal development leads to a suite of permanent
deficits in experimental animals and humans [1]. The liver plays a
critical role in metabolism, serum glucose and lipid regulation and
is a major target organ of TH. Previous studies using compre-
hensive transcriptional arrays have shown that TH regulates the
expression of genes involved in these important physiological
processes [2,3]. However, the mechanism by which TH regulates
the expression of these genes, whether by direct actions on
transcriptional activity or by indirect actions on mechanisms that
control cellular levels of mRNAs, is not well understood.
MicroRNAs (miRNAs) are small non-coding RNAs of 19–24
nucleotides in length that are important regulators of crucial
biological processes, such as metabolism, cell growth, apoptosis
and carcinogenesis [4,5]. The number of known miRNAs has
rapidly increased over the past years. Recently, the Sanger
Institute released the latest version of their database of known
miRNAs (miRBase 14.0; Sep 2009, http://microrna.sanger.ac.
uk); 786 mature mouse miRNA sequences are currently reported.
Long primary miRNAs are transcribed by RNA polymerase II in
the nucleus, and then modified by an enzyme complex containing
DROSHA and DGCR8 to form pre-miRNA. Subsequent
cleavage of pre-miRNA by an RNase III, DICER 1, results in
mature miRNA, which suppresses translation and enhances
degradation of target gene transcripts by binding to complemen-
tary regions within the target transcripts [4,5].
Considering the importance of TH in regulating fundamental
processes governed by hepatic function, and the potential
importance of miRNAs in regulating genes coding for proteins
important in these function, we sought to test the hypothesis that
TH regulates specific miRNAs. Therefore, we employed DNA
microarrays and TaqMan low density arrays (TLDA) to analyze
gene and miRNA expression profiles in a juvenile hypothyroid
mouse model induced by short-term exposure of dams to
goitrogen before weaning. TLDA offers a high throughput and
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were examined in more detail in other animal models with altered
TH levels and in an in vitro system to confirm TH regulation. The
target genes of one miRNA (miR-206) were investigated with cell
lines stably transfected with the corresponding miRNA. Analysis of
miRNA expression changes in combination with global mRNA
levels provides a powerful approach to determine the effect of TH
perturbation on miRNA expression and function. The results of
this study provide insight into the role of miRNAs in mediating the
actions of TH on liver function.
Materials and Methods
Ethics Statement
All animal care and handling was in accordance with Canadian
Council for Animal Care Guidelines and was approved by the
Health Canada Animal Care Committee. Permit number is
2007006.
Animal models with altered TH level
C57BL/6 mice were purchased from Charles River (St.
Constant, QC, Canada) and were housed in hanging polycarbon-
ate cages under a 12:12 hour light-dark cycle at 23uC with food
(Purina rodent chow 5010; Ralston-Purina, St. Louis, MO, USA)
and sugar water (1%) available ad libitum. All cages contained
shelters and nesting material. After a 10 day acclimation period
breeding was initiated by transferring two sexually mature female
mice (8 weeks post natal) into the home cage of a sexually mature
(10 weeks) male. After 4 nights of co-housing each female was
transferred to a separate cage. Dams were allowed to litter
naturally and litter numbers were not adjusted. On post natal day
(PND) 12, half of the dams with litters were provided with sugar
water containing methimazole (MMI, 0.05%, Sigma Chemical, St.
Louis, MO) and perchlorate (1%, Sigma chemical), while other
half were provided sugar water. Four hours before sacrifice on
PND 15, pups with sugar water were injected with PBS (control
group) or T4/T3 (hyper group, 50/5ug/100gbw); MMI and
perchlorate treated pups were injected with PBS (hypo group) or
T4/T3 (hypo+ group, 20/2ug/100gbw).
For PTU induced hypothyroidism, C57BL/6 time-pregnant
mice (13-day gestation, GD 13) were purchased from Charles
River (St. Constant) and supplied ad libitum with 0.3% diet cherry
Kool-aid in water containing 0%(control) or 0.04% PTU (6-
propylthiouracil; Sigma Chemical) from GD 13 to PND 15.
On PND 15, a male pup from each litter was sacrificed by
exsanguination under isofluorane anaesthesia. Serum, prepared
using Serum Separator Tubes (BD Biosciences, Mississauga, ON,
Canada) was retained for T4 analysis with RIA kits (MP
Biomedicals, Medicorp, Montreal, QC, Canada). Liver was
dissected as rapidly as possible, immediately frozen in liquid
nitrogen and stored at 280uC.
Cell culture and stable transfection
Mouse hepatocyte cells AML 12 (ATCC, Manassas, VA,USA)
were grown at 37uC in Dulbecco’s modified Eagle’s medium/
Ham’s F-12 nutrient mixture with 10% fetal Bovine serum,
100 nM dexamethasone and ITS (insulin, transferrin and
selenium, Invitrogen, Burlington, ON, Canada). Stable transfec-
tion was performed using 18 ml FuGene (Roche, Indianapolis, IN,
USA) with 12 mg miRNASelect pEGP-mir Null Control Vector or
pEGP-mmu-mir-206 Expression Vector (Cell Biolabs, Inc., San
Diego, CA, USA) in 10-mm Petri dishes. Green clones in the
medium containing 2 mg/ml puromycin (Invitrogen) were identi-
fied by microscopy, and were picked and cultured in completed
medium with puromycin for one week. The over expression of
miR-206 was confirmed with qRT-PCR. Ten percent stripped
fetal bovine serum (Medicorp, QC, Canada) was added to
cultured cells one day before cells were incubated with or without
10 nM T3.
RNA Extraction and Purification
For microarray analysis, total RNA was extracted with TRIzol
reagent (Invitrogen) followed by RNeasy Mini Kit (Qiagen,
Mississauga, ON, Canada) clean-up according to the manufac-
turer’s instructions. RNA integrity was determined using an
Agilent 2100 Bioanalyzer (Agilent Tech. Inc. Mississauga, ON,
Canada) and only high quality RNA (RIN.9.0) was used for
microarray analysis. For other analyses (miRNA expression, qRT-
PCR), total RNA was extracted with mirVana miRNA Isolation
Kits (Ambion, Inc., Applied Biosystems, Foster city, CA, USA)
according to the manufacturer’s instructions.
Microarray hybridization
Relative transcript levels were determined using a 2 colour
reference hybridization design where each RNA sample was
labelled with Cyanine 5-CTP (Cy5) and universal mouse reference
total RNA (Stratagene, Cedar Creek, TX, USA) was labelled with
Cyanine 3-CTP (Cy3) using Agilent Quick Amp Labelling kits
(Agilent Tech. Inc.). Labelled sample and common reference
cRNA were hybridized to Agilent mouse oligo microarrays
(product number G4122F; 4X44K arrays) according to the
manufacturer’s instructions. Slides were washed and scanned on
an Agilent G2505B microarray scanner and data were acquired
with Agilent Feature Extraction software version 10.1.1.1.
Microarray normalization and analysis of differential gene
expression
Background fluorescence was measured using the (-)3xSLv1
probes. Probes exhibiting median signal intensities less than the
trimmed mean (trim=5%) plus three trimmed standard deviations
of the (-)3xSLv1 probe were flagged as absent (within the
background signal). Data were normalized using the transform.
madata function in the MAANOVA library in R using a global
lowess with a span of 0.2 [7,8]. Genes that were differentially
expressed as a result of treatment were determined using the
MAANOVA library in R. The Fs statistic [9] was used to test for
treatment effects. P-values were estimated by the permutation
method using residual shuffling, followed by adjustment for
multiple comparisons using the false discovery rate (FDR)
approach [10]. The fold change calculations were based on the
least-square means. Significant genes were identified as those
where the Fs statistic had a Benjamini-Hochberg corrected
p,0.05. All data are MIAME compliant and available through
the Gene Expression Omnibus (GEO, accession num-
ber GSE21277).
MiRNA expression analysis with TLDA
Four male mice from each of the control and hypo groups
respectively were used to comprehensively analyze miRNA
expression. Samples containing 750 ng RNA were used to perform
reverse transcription with the Taqman miRNA Reverse Tran-
scription kit and Megaplex RT Primers Rodent Pool A and B
(Applied Biosystem). RT-PCR reactions were performed with
TaqMan Rodent miRNA Array A and B (containing up to 600
rodent miRNAs) by the Institut de Recherche en Immunologie et
en Cance ´rologie (IRIC), University de Montreal, with the 7900
HT system. Using the log2 of the delta Ct values, differentially
miRNAs in TH Response
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housekeeping miRNA. The critical value of the F-test statistic was
determined by bootstrapping the residuals from the one way
ANOVA model [11] using the R [7] software. Residuals were re-
sampled within each treatment condition to avoid making the
common variance assumption [12]. Multiple comparison adjust-
ment was applied to the final results using the FDR approach [10].
The dataset is available through GEO (accession num-
ber GSE21277).
miRs-1, 206, 133a and 133b expression in animal models
or cultured cell lines
Taqman miRNA Reverse Transcription kits (Applied Biosys-
tem) were used for reverse transcription reactions with 10 ng total
RNA as template and specific primers from the Taqman miRNA
Assay Kits. PCRs were performed with Taqman universal PCR
Master Mix according to the manufacturer’s instructions. Three
animals from each group or 3 batches of cultured cells were used.
Relative miRNA expression was analyzed using the DDCt method
with U6 as a housekeeping miRNA and one of the control samples
as the calibrator. Significant differences in expression were
determined using a Student’s t-test and called significant if
p,0.05.
MiRNA target predictions
TargetScan mouse 5.1 (http://www.targetscan.org/mmu_50/)
and MicroCosm Targets Version 5 (http://www.ebi.ac.uk/enright-
srv/microcosm/cgi-bin/targets/v5/search.pl) were used to predict
the targets of miRs-1, 206, 133a and 133b. Genes predicted
by either of algorithm were considered to be the targets. These
softwares apply different algorithms to identify the highly
complementary sites and are widely used for miRNA target
prediction [13–15].
qRT-PCR analysis of target genes and precursors of
miRNAs
Reverse transcription was carried out with SuperScript III
(Invitrogen) using SYBR-Green and a GFX system (BioRad,
Mississauga, ON, Canada). Primers were designed using Beacon
design 2.0 (Premier BioSoft International, Palo Alto, CA, USA).
PCR reactions were performed in duplicate, and the values of the
threshold cycles were averaged. Gene expression levels were
normalized to Hprt. PCR efficiency was examined using the
standard curve for each gene. The primer specificity was assured
by the melting curve for each gene. A Student’s t-test was used for
statistical evaluation. The sequences of primers are available upon
request.
Results
Validation of the short-term MMI/perchlorate-induced
hypothyroid juvenile mouse model
Serum T4 levels in PND 15 male pups of dams treated from
PND 12 to PND 15 with drinking water containing 0.05% MMI/
1% perchlorate were significantly reduced (p,0.001, Fig. 1A).
Functional hypothyroidism was further confirmed by the obser-
vation of a 50% reduction in malice enzyme (a known TH
regulated gene in liver [3]) expression in hypothyroid mouse liver
(Fig. 1B).
MiRNA expression in hypothyroid mice
The TLDA analysis revealed that 40 miRNAs were significantly
altered (p,0.1) in the liver of hypothyroid mice compared with
controls. Among them, 11 miRNAs exhibited a fold change
greater than 4 (Table 1); 8 of these 11 (70%) were up-regulated in
hypothyroid mice. Three miRNA families (miRs-1 and 206, miRs-
133a and 133b as well as miRs-135a and 135b) exhibited very
large increases in expression (ranging from 50- to 500-fold). Data
for these findings are available through GEO, accession
number GSE21277.
The expression of miRs-1, 206, 133a, 133b in other animal
models with altered TH levels
To further investigate the effect of TH on hepatic miRNA
expression, we examined the expression of the most differentially
regulated miRNAs (miRs-1, 206, 133a, 133b) in the livers of (a)
hypothyroid mice induced by PTU treatment (PTU hypothyroid);
(b) hyperthyroid mice created by injecting T3/T4 four hours
before sacrifice (hyperthyroid) and (c) hypothyroid mice induced
by MMI/Perchlorate treatment but receiving T4/T3 injection
four hours before sacrifice (corrected hypothyroid). Three mice
were chosen from each group and their serum T4 levels were
shown in Table 2. As shown in Fig. 2A, all of four selected
miRNAs were significantly increased in the livers of PTU induced
Figure 1. Serum T4 levels and liver malic enzyme mRNA levels in mouse pups rendered hypothyroid by 3 day exposure of dams
and their litters to drinking water containing MMI and perchlorate from PND 12 to 15. A. Serum T4 data are expressed as mean 6
standard error (SE, n=10) and * indicates significant difference (p,0.001). B. qRT-PCR for malic enzyme mRNA (positively regulated by direct TH
action) was performed with RNA derived from male pups. Data are presented as mean 6 SE (n=5). A two-tailed Student’s t-test was used to calculate
significance and * indicates p=0.03.
doi:10.1371/journal.pone.0012136.g001
miRNAs in TH Response
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hyperthyroid mice. Corrected hypothyroid animals had serum T4
levels intermediate between control and hyper thyroid animals
although these were only significantly different from the
hyperthyroid T4 levels (p=0.046 vs hyperthyroid and 0.067 vs
control; Table 2). Similarly, hepatic expression of all 4 miRNAs
was also intermediate between control and hyperthyroid mice with
only miR206 being significantly reduced relative to control
animals (Fig 2B).
The expression of miRs-1, 206, 133a and 133b in AML 12
cells treated with TH
To further explore the effects of TH on miRNA regulation in
liver, we treated AML 12 cells (derived from mouse hepatocytes)
with 10 nM T3 for 1 hour or 24 hours. The expression of miRs-1,
206, 133a and 133b was examined with the Taqman miRNA
Assay. TH treatment caused down-regulation of all miRNAs
examined at both 1 hour and 24 hours, although this effect was
only statistically significant for miRs-1, 206 and 133b at 24 hours
(Fig. 3A).
Since mature miRNAs are derived from the cleavage of
precursors by the RNase-III enzyme DICER, we investigated
the effects of TH on the levels of the precursors of the selected
miRNAs in AML 12 cells. As significant decreases of mature
miRNAs were only found at 24 hours, we examined the precur-
sor miRNAs at 24 hours as well. Precursors of all 4 miRNA species
were reduced by at least 50% and this reduction was statistically
significant (p,0.05) for mir-206 and mir-133b (Fig. 3B) even with
the small sample size used.
Target Genes of miRs-1, 206, 133a and 133b in
hypothyroid mouse liver
The livers of five male pups from the transient hypothyroid
model were analysed using Agilent gene expression microarrays
alongside controls. Significantly altered genes (p,0.05) were found
for 103 transcripts between euthyroid and hypothyroid pups.
Among them, 92 genes have known functions and include genes
known to be regulated by TH, such as Dio1, Spot 14 and Vldlr
[3]. The expression of malic enzyme was also decreased in these
hypothyroid mice (1.4-fold, unadjusted p-value=0.005), consistent
with the result of qRT-PCR (Fig. 1B). Detailed analysis of the
expression profiles of these mice will be presented as part of
another publication (Paquette et al., in preparation). The dataset is
available through GEO (accession number GSE21277). Because
miRs-1and 206 as well as miRs-133a and 133b families exhibited
such large fold changes, the targets of these miRNAs were
predicted using TargetScan and MicroCosm. The overlap
between predicted target genes and significantly changed genes
with fold change .1.5 and p,0.05 in hypothyroid mice is shown
in Table 3. Of the 14 predicted targets, 11 were significantly
down-regulation in hypothyroid pups, corresponding with the up-
regulation of miRs-1, 206, 133a and 133b. None of the targets of
miRs-1, 206, 133a and 133b that were curated in TarBase (http://
diana.cslab.ece.ntua.gr/tarbase/) were altered in the hypothyroid
mouse livers.
To provide direct evidence of the regulation of the expression of
target genes by miRNAs in response to TH, we established AML
12 cells that over-expressed mir-206 by stable transfection of
Table 1. Differentially expressed miRNAs in hypothyroid mouse liver (p,0.1, Fold change .4).
Gene Name Fold Change p-value Clustered miRNA* Function
miR-133 family
mmu-miR-133b 501.39 0.05 mmu-miR-206 Apoptosis [24], muscle development [25,26]
mmu-miR-133a 100.36 0.02 mmu-miR-1 Apoptosis [24], muscle development [25,26]
miR-1/206 family
mmu-miR-1 92.11 0.01 mmu-miR-133a Apoptosis [24], muscle development [25,26]
mmu-miR-206 58.90 0.07 mmu-miR-133b Apoptosis [24], muscle development [25,26]
miR-135 family
mmu-miR-135b 85.11 0.09 Colorectal cancer [27]
mmu-miR-135a 14.62 0.09 Colorectal cancer [27]
Others
mmu-miR-138* 27.77 0.08 Squamous cell carcinoma [28]
mmu-miR-199b* 4.96 0.05 Choriocarcinoma [29]
mmu-miR-148a* 24.20 0.04 DNA methyltransferase [30]
mmu-miR-582-5p 25.14 0.07 Malignant mesothelioma [31]
mmu-miR-200a* 25.49 0.10 Cervical cancer [32]
*indicates they are in the same chromosome and apart less than 10kb (based on database of TargetScan).
doi:10.1371/journal.pone.0012136.t001
Table 2. Serum T4 levels of male pups in the various animal
models (n=3).
T4 (mg/dl) p
Chronical Hypothyroid
Control 9.93
PTU (0.04%) 0.57 0.000
Transient Models
Control 9.6
Hyper 39.4 0.000
Hypo+ 16.6 0.067 (to Control)
0.046 (to Hyper)
doi:10.1371/journal.pone.0012136.t002
miRNAs in TH Response
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was approximately 1500 times higher in miR-206 over-expressing
cells than in mir null control vector transfected cells (Fig. 4A). We
selected 4 down-regulated genes from the predicted miR-206
targets in Table 3. The expression of these genes was examined in
these cells and the results are shown in Figure 4B. Expression of
three out of the four putative target genes were significantly
decreased in miR-206 over expressed cells suggesting that these
three genes are true targets of miR-206.
To investigate whether these 3 true target genes are regulated
by TH, we examined the expression of these 3 genes and that of
miR-206 in miR-206 transfected AML 12 cells treated with T3 for
24 hours. T3 treatment decreased the expression of miR-206 by
roughly 50% (p,0.05) in miR-206 transfected AML 12 cells
(Fig. 4C), while the expression of target genes Gpd2 and Mup1,
but not Nrp1, significantly increased (Fig. 4D).
Discussion
TH are essential for normal development and for normal adult
physiology. In both development and in adulthood, an important
role of TH is to control metabolism and, perhaps, body weight.
Recent studies on the effects of a TRb-selective drug that targets
the liver indicate that activation of the TRb receptor can lower
serum lipids, can decrease global fat stores, and can improve
insulin tolerance in ob/ob mice [16]. Thus, liver is an important
target of TH in regulating energetic metabolism and physiology
[2,3]. TH primarily exert their effects through interaction with
TR, which, upon heterodimerization with the retinoic X receptor,
acts as ligand–activated transcription factors to initiate or block
target gene expression by binding to TH response elements (TREs)
in the gene promoter regions. Indeed, much of the focus of work in
our laboratory has been on the identification of TREs associated
with promoters [17]. However, a direct TR-TRE mechanism may
not explain all TH actions. For example, non-genomic action of
TH, which is often related to activation of signalling pathways, is
another well characterized TH response [18]. MiRNAs represent
an additional mechanism by which TRs may regulate or
coordinate TH response genes. MiRNAs are involved in many
biological processes and functions in controlling protein expression
through targeting degradation of mRNA, translational suppression
of protein production, and directing chromatin structure (reviewed
in [19]). As such, in the current work we explored the role of
miRNAs in governing TH response.
To examine the possibility that TH action may influence
miRNA expression which could, in turn, alter mRNA levels, we
generated hypothyroid mice by short-term treatment with MMI
and perchlorate. Global expression of miRNAs and mRNAs were
studied with TLDA and DNA microarray technologies. TLDA (a
modified qRT-PCR method) was applied to generate miRNA
Figure 2. Expression of miRs-1, 206, 133a and 133b in other animal models with altered TH levels. A. Hepatic miRNA expression in livers
of PND 15 mouse pups rendered hypothyroid by treatment with drinking water containing 0.04% (wt/vol) of PTU from GD 13 to PND 15. RT-PCR was
performed with the Taqman miRNA Assay with RNA derived from male pups (3 per group). B. Hepatic miRNA expression in livers of PND 15 mice
whose TH levels were modulated as follows: hyperthyroid pups (hyper) received a s.c. injection of T4+T3 (50 mg+5 mg, respectively per 100g bw) four
hours prior to sacrifice and corrected hypothyroid pups received drinking water containing MMI and perchlorate (0.05 and 1% wt/vol, respectively)
from PND 12 to 15 and an injection of T4+T3 (20 mg+2 mg, respectively per 100g bw) four hours prior to sacrifice, while control mice received an
injection of PBS only. RT-PCR was performed with the Taqman miRNA Assay with RNA derived from male pups (3 per group). Data are presented as
mean 6 SE (n=3). A two-tailed Student’s t-test was used to calculate significance. * indicates p,0.05.
doi:10.1371/journal.pone.0012136.g002
miRNAs in TH Response
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and accuracy relative to microarrays, and demonstrates a 100%
miRNA expression validation rate against standard qRT-PCR [6].
We detected 40 significantly altered miRNAs (p,0.1) in the livers
of hypothyroid mice. Among these, 11 miRNAs exhibited fold
change .4 (Table 1) and included 8 up-regulated and 3 down-
regulated miRNAs. Remarkably, miRs-1, 206, 133a and 133b
exhibited fold changes in excess of 50-fold. MiR-1 and miR-133a
cluster on chromosome 2 within 10 kb, while miR-206 and miR-
133b cluster on chromosome 1 within 4 kb. The results
demonstrate a highly robust induction of miRNAs in response to
hypothyroidism for specific genomic sites.
To demonstrate that the increased miRNA expression was
induced by TH deficiency, not the toxicity of MMI and
perchlorate, we examined the expression of miRs-1, 206, 133a
and 133b in chronic hypothyroid, short-term hyperthyroid and a
TH-supplemented transient hypothyroid animal models using RT-
PCR. All of the miRNAs significantly increased in the chronically
hypothyroid mouse liver, although the fold change was smaller
than in the transient hypothyroid model (Fig. 2A). This may be
attributed to the different animal models or different detection
systems used. Alternatively, there may be some adaptation
following chronic hypothyroidism, or the miRNAs may exhibit a
large initial response to the TH perturbation. This increased
miRNA expression was not seen in TH corrected transient
hypothyroidism, while miR-206 was significantly decreased
(Fig. 2B). In addition, all selected miRNAs were significantly
decreased in hyperthyroid mouse livers. That both serum T4
(Table 2) and hepatic expression of these miRNAs in the corrected
hypothyroid animals are intermediate between control and
hyperthyroid animal suggests an inverted dose dependant
regulation by TH of these miRNA levels. These observations
were confirmed in an in vitro model of mouse hepatocytes (AML 12
cells), where treatment with T3 caused a rapid (1 hour) reduction
in the levels of miRs-1, 206, 133a and 133b. Further reduction of
miRs-1 and 133a was found 24 hours post-treatment (Fig. 3A).
The expression of miRNA precursors decreased with T3
treatment at 24 hrs (Fig. 3B). Although some of these changes
were not significant at the p,0.05 level (only three biological
replicates were used in these analyses), the data in vitro provide
more evidence that TH reduce the cellular levels of miRs-1, 206,
133a and 133b at the transcript level.
TH regulation of these miRNAs is also supported by recent
studies on muscle miRNA expression in hypothyroid humans [20].
In this work Visser et al. collected skeletal muscle biopsies from
clinically hypothyroid patients who were being treated with TH or
not. The authors found that TH induced a large down-regulation
of primary miRs-206 and 133b. Levels of the primary transcript
associated with miRs-1 and 133a were also reduced but to a lesser
extent. Together these findings provide strong evidence that TH
Figure 3. Expression of miRs-1, 206, 133a and 133b as well as their precursors in the AML 12 cells. A. AML 12 cells were treated with
10 nm T3 for 1 hour or 24 hours. The expression of miRs-1, 206, 133a and 133b was examined with the Taqman miRNA Assay. U6 was used as an
internal control. Five batches of cultured cells were considered as 5 biological replicates. B. The expression of the precursors of miRs-1, 206, 133a and
133b was examined in AML 12 cell treated with 10 nm T3 for 24 hours with RT-PCR. Hprt was used as internal control. Three batches of cultured cells
were used as 3 biological replicates. Data are presented as mean 6 SE. A two-tailed Student’s t-test was used to calculate significance. * indicates
p,0.05.
doi:10.1371/journal.pone.0012136.g003
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.1.5).
Accession Number Gene Symbol p-value Fold Change Description
Targets of miR-1/206
NM_013703
a Vldlr* 0.001 1.669 very low density lipoprotein receptor
NM_001013785
a Akr1c19 0.000 1.612 aldo-keto reductase family 1, member C19
NM_029692
a Upp2 0.008 21.562 uridine phosphorylase 2
NM_010274
b Gpd2 0.000 21.695 glycerol phosphate dehydrogenase 2, mitochondrial
NM_031188
a Mup1 0.003 21.815 major urinary protein 1
NM_008737
b Nrp1* 0.000 22.000 neuropilin 1
NM_026460
a Serpini2 0.001 23.080 serine (or cysteine) peptidase inhibitor, clade I, member 2
Targets of miR-133a/b
NM_016919
a,b Col5a3 0.000 1.752 procollagen, type V, alpha 3
NM_182959
a Slc17a8 0.000 21.637 solute carrier family 17
NM_025989
a Gp2 0.002 21.727 zymogen granule membrane glycoprotein 2
NM_009344
a Phlda1* 0.000 21.815 pleckstrin homology-like domain, family A, member 1
NM_008693
a Klk1b3 0.002 22.103 kallikrein 1-related peptidase b3
NM_010639
a Klk1 0.001 22.111 kallikrein 1
NM_007769
a Dmbt1 0.004 24.236 deleted in malignant brain tumors 1
*indicates the genes that were found in chronic hypothyroidism in our previous study [3].
a indicates the genes were predicted with the database of MicroCosm Targets and b indicates with TargetScan Mouse.
doi:10.1371/journal.pone.0012136.t003
Figure 4. Identification of the target genes of miR-206 that are regulated by TH. A. Levels of miR-206 in AML 12 cells stably transfected to
ectopically express miR-206. AML12 cells were transfected with pEGP-mmu-mir-206 expression vector or pEGP-mir null control vector and selected
with puromycin and green florescence protein by microscopy. The expression of miR-206 was examined with the Taqman miRNA Assay (n=5). B. The
expression of genes that are putative targets of miR-206 in the two cell types shown in figure 4A was examined with RT-PCR (n=3). C. The effects of
TH on the expression of miR-206 in the transfected cells. The miR-206 transfected cells were treated with 10 nm T3 for 24 hours. MiR-206 expression
was analyzed with Taqman miRNA Assay (n=3). D. The effect of TH on the expression of the miR-206 target genes in the transfected cells. The miR-
206 transfected cells were treated with 10 nm T3 for 24 hours. The expression of target genes was examined with RT-PCR (n=3). Data are presented
as mean 6 SE. A two-tailed Student’s t-test was used to calculate significance. * indicates p,0.05.
doi:10.1371/journal.pone.0012136.g004
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liver and skeletal muscle. However, the targets of these miRNAs
and the potential biological implications are not known.
In order to explore the correlation between miRNA and
mRNA levels, gene expression microarrays were used to quantify
transcript abundance in the livers of the same mice (hypothyroid
and euthyroid). Significant alterations in mRNA levels (p,0.05)
were found for 92 transcripts with known functions between
euthyroid and hypothyroid pups. Changes in gene expression
may be regulated by TH through TR-TRE, miRNAs, non-
genomic signalling or other mechanisms. Targets of miRs-1, 206,
133a and 133b were predicted using TargetScan and Micro-
Cosm. The analysis predicts that these miRNAs target 14 genes
that also exhibited changes in mRNA levels in hypothyroid mice
relative to controls (Table 3). The vast majority of these mRNA
targets (11/14) were down-regulated under hypothyroid condi-
tions, corresponding with the increased expression of miRs-1,
206, 133a and 133b in these mice. Three targets (Vldlr, Nrp1 and
Phlda1) have previously been found to be differentially expressed
following alterations in TH levels in mouse livers [3]. We further
validated the targets of miR-206 by establishing over-expressing
miR-206 in AML 12 cells by stable transfection. The expression
of miR-206 was approximately 1500 times higher in the
transfected cells relative to control cells (Fig. 4A). The expression
of four predicted targets of miR-206 that were down-regulated in
hypothyroid livers was examined; 3 of them were decreased
significantly in miR-206 transfected cells (Fig. 4B). These findings
strongly suggest that these 3 genes are putative targets of miR-
206. To further demonstrate that miR-206 targets are regulated
by TH, we treated the miR-206 transfected cells with TH for
24 hours and found that the expression of miR-206 decreased
significantly (Fig. 4C), and was accompanied by increases in the
expression of 2 of the miR-206 target genes (Mup1 and Gpd2,
Fig. 4D). Mup1 mediates chemical signalling by acting as
pheromone ligand and regulates systemic glucose and lipid
metabolism [21,22], while Gpd2 plays a role in thermogenesis
[23]. TH are involved in the regulation of the activities of Mup1
and Gpd2. Our current findings provide possible mechanisms by
which TH regulates these activities via post-transcriptional
control by miR-206.
These findings suggest that TH may regulate the cellular levels
of several species of miRNA which, in turn, regulate the mRNA
levels of some genes. To our knowledge, this represents the first
observation of miRNA mediating the physiological action of a
hormone in the development of the liver. At present, it is not clear
if TH reduces the levels of these specific miRNAs by blocking
transcription of primary genes or through some other mechanisms.
Further confirmation of the target genes and the physiological
significance of miRNAs in regulating TH function are underway
in our laboratory.
In conclusion, the present study applied global miRNA and
mRNA expression profiling to reveal a potential regulatory role for
miRNAs in response to TH in the developing mouse liver. Two
target genes of miR-206 affected by TH were confirmed in vitro.
The work provides insight into the mechanisms leading to
abnormal metabolism and development in the liver following
TH imbalance.
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